These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11932495)

  • 1. A recombinant bacterial cell surface (S-layer)-major birch pollen allergen-fusion protein (rSbsC/Bet v1) maintains the ability to self-assemble into regularly structured monomolecular lattices and the functionality of the allergen.
    Breitwieser A; Egelseer EM; Moll D; Ilk N; Hotzy C; Bohle B; Ebner C; Sleytr UB; Sára M
    Protein Eng; 2002 Mar; 15(3):243-9. PubMed ID: 11932495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of the S-layer gene, sbpA, of Bacillus sphaericus CCM 2177 and production of a functional S-layer fusion protein with the ability to recrystallize in a defined orientation while presenting the fused allergen.
    Ilk N; Völlenkle C; Egelseer EM; Breitwieser A; Sleytr UB; Sára M
    Appl Environ Microbiol; 2002 Jul; 68(7):3251-60. PubMed ID: 12089001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of an endotoxin-free S-layer/allergen fusion protein in gram-positive Bacillus subtilis 1012 for the potential application as vaccines for immunotherapy of atopic allergy.
    Ilk N; Schumi CT; Bohle B; Egelseer EM; Sleytr UB
    Microb Cell Fact; 2011 Feb; 10():6. PubMed ID: 21310062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity.
    Bohle B; Breitwieser A; Zwölfer B; Jahn-Schmid B; Sára M; Sleytr UB; Ebner C
    J Immunol; 2004 Jun; 172(11):6642-8. PubMed ID: 15153479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the structure-function relationship of the S-layer protein SbsC of Bacillus stearothermophilus ATCC 12980 by producing truncated forms.
    Jarosch M; Egelseer EM; Huber C; Moll D; Mattanovich D; Sleytr UB; Sára M
    Microbiology (Reading); 2001 May; 147(Pt 5):1353-1363. PubMed ID: 11320138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to specific allergy treatment: the recombinant allergen-S-layer fusion protein rSbsC-Bet v 1 matures dendritic cells that prime Th0/Th1 and IL-10-producing regulatory T cells.
    Gerstmayr M; Ilk N; Schabussova I; Jahn-Schmid B; Egelseer EM; Sleytr UB; Ebner C; Bohle B
    J Immunol; 2007 Dec; 179(11):7270-5. PubMed ID: 18025169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
    Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
    J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of a functional monomolecular protein lattice consisting of an s-layer fusion protein comprising the variable domain of a camel heavy chain antibody.
    Pleschberger M; Neubauer A; Egelseer EM; Weigert S; Lindner B; Sleytr UB; Muyldermans S; Sára M
    Bioconjug Chem; 2003; 14(2):440-8. PubMed ID: 12643755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering, purification and applications of His-tagged recombinant antibody fragments with specificity for the major birch pollen allergen, bet v1.
    Flicker S; Laffer S; Steinberger P; Alhani B; Zhu Y; Laukkanen ML; Keinänen K; Kraft D; Valenta R
    Biol Chem; 2000 Jan; 381(1):39-47. PubMed ID: 10722049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dipstick developed for rapid Bet v 1-specific IgE detection: recombinant allergen immobilized via a monoclonal antibody to crystalline bacterial cell-surface layers.
    Breitwieser A; Mader C; Schocher I; Hoffmann-Sommergruber K; Aberer W; Scheiner O; Sleytr UB; Sára M
    Allergy; 1998 Aug; 53(8):786-93. PubMed ID: 9722228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.
    Ferreira F; Hirtenlehner K; Jilek A; Godnik-Cvar J; Breiteneder H; Grimm R; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Breitenbach M; Rheinberger HJ; Ebner C
    J Exp Med; 1996 Feb; 183(2):599-609. PubMed ID: 8627171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
    Movérare R; Westritschnig K; Svensson M; Hayek B; Bende M; Pauli G; Sorva R; Haahtela T; Valenta R; Elfman L
    Int Arch Allergy Immunol; 2002 Aug; 128(4):325-35. PubMed ID: 12218371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season.
    van Hage-Hamsten M; Kronqvist M; Zetterström O; Johansson E; Niederberger V; Vrtala S; Grönlund H; Grönneberg R; Valenta R
    J Allergy Clin Immunol; 1999 Nov; 104(5):969-77. PubMed ID: 10550741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of allergen (Bet v 1) conjugated to crystalline bacterial cell surface layers (S-layers).
    Jahn-Schmid B; Graninger M; Glozik M; Küpcü S; Ebner C; Unger FM; Sleytr UB; Messner P
    Immunotechnology; 1996 Jun; 2(2):103-13. PubMed ID: 9373319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Bet v 1 isoforms including a naturally occurring truncated form of the protein derived from Austrian birch pollen.
    Friedl-Hajek R; Radauer C; O'Riordain G; Hoffmann-Sommergruber K; Leberl K; Scheiner O; Breiteneder H
    Mol Immunol; 1999 Jul; 36(10):639-45. PubMed ID: 10509815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a sensitive and stable chemiluminescent immunoassay for detection of birch pollen allergic specific IgE based on recombinant Bet v1 protein.
    Gao J; Cai R; Zhou N
    J Immunol Methods; 2021 Jun; 493():113040. PubMed ID: 33741388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
    Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
    Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding properties.
    Breiteneder H; Ferreira F; Hoffmann-Sommergruber K; Ebner C; Breitenbach M; Rumpold H; Kraft D; Scheiner O
    Eur J Biochem; 1993 Mar; 212(2):355-62. PubMed ID: 7916686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of recombinant isoforms of birch pollen allergen Bet v 1.
    Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Osmark P; Poulsen FM; Larsen M; Mørtz E; Roepstorff P; Larsen JN
    Adv Exp Med Biol; 1996; 409():251-4. PubMed ID: 9095250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved epitope-specific T cell activation by recombinant Bet v 1-MBP fusion proteins.
    van Neerven RJ; Sparholt SH; Schou C; Larsen JN
    Clin Exp Allergy; 1998 Apr; 28(4):423-33. PubMed ID: 9641568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.